Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Other neoplasm 1Myeloid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Myelodysplastic Syndromes 14Hodgkin Disease 10Hematologic Neoplasms 10Leukemia, Myelogenous, Chronic, BCR-ABL Positive 9Leukemia 8Lymphoma, Non-Hodgkin 7Myeloproliferative Disorders 6Multiple Myeloma 6Leukemia, Lymphocytic, Chronic, B-Cell 6Graft vs Host Disease 6Waldenstrom Macroglobulinemia 5Lymphoma 5Leukemia, Myelomonocytic, Chronic 5Lymphoma, Mantle-Cell 4Lymphoma, Large B-Cell, Diffuse 4Leukemia, Biphenotypic, Acute 4Anemia, Refractory, with Excess of Blasts 4Primary Myelofibrosis 3Myelodysplastic-Myeloproliferative Diseases 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Prolymphocytic 3Congenital Abnormalities 3Blast Crisis 3Anemia, Aplastic 3Thrombocythemia, Essential 2Sezary Syndrome 2Recurrence 2

Interventions

Cyclophosphamide 4fludarabine phosphate 3ibrutinib 2fludarabine 2Whole-Body Irradiation 2Tacrolimus 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Mesna 2Bone Marrow Transplantation 2pirtobrutinib 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1Surveys and Questionnaires 1Patient Reported Outcome Measures 1Melphalan 1Busulfan 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Leukemia, Lymphoid × Mycophenolic Acid × 90 days × Clear all
NCT03670966 2026-05-04

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

Fred Hutchinson Cancer Center

Phase 1/2 Recruiting
30 enrolled
Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Lymphoid, Leukemia, Monocytic, Acute, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04904588 2026-03-18

ACCESS

Center for International Blood and Marrow Transplant Research

Phase 2 Active not recruiting
300 enrolled
LymphoidMyeloidOther hematologic neoplasmOther neoplasm

Bone Marrow Diseases, Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Leukemia, Lymphoid, Leukemia, Myeloid, Lymphatic Diseases, Lymphoma, Lymphoproliferative Disorders, Myelodysplastic Syndromes, Neoplasms, Neoplasms by Histologic Type, Precancerous Conditions, Preleukemia, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡